Trident Texofab standalone net profit rises 666.67% in the December 2022 quarter
Sales rise 2.94% to Rs 24.55 crore
Net profit of Trident Texofab rose 666.67% to Rs 1.15 crore in the quarter ended December 2022 as against Rs 0.15 crore during the previous quarter ended December 2021. Sales rose 2.94% to Rs 24.55 crore in the quarter ended December 2022 as against Rs 23.85 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales24.5523.85 3 OPM %8.846.75 -PBDT1.990.97 105 PBT1.590.58 174 NP1.150.15 667Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content